Ufiprazole is primarily used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of proton pump inhibitors (PPIs). These inhibitors are widely employed in the treatment of gastric acid-related disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Due to its role in forming active pharmaceutical ingredients, ufiprazole contributes to the production of drugs that effectively reduce stomach acid secretion by targeting the H+/K+ ATPase enzyme system in the gastric mucosa. Its application in drug manufacturing emphasizes its importance in enhancing the efficacy and stability of final therapeutic agents.